Jack brings with him over a decade of experience in drug discovery across multiple disciplines including medicinal chemistry, analytical chemistry, DMPK and metabolite identification. This combination of experience has equipped him well in helping to drive the expansion of the Extractables & Leachables expertise at Element Manchester.
Prior to joining Element, Jack had over 10 years experience in drug discovery and pharmacokinetics. Jack began his Extractables & Leachables journey as a Study Director when he joined the team at Hall (now Element Manchester) in 2018. Since then, Jack has applied his strong technical background to grow the scientific capacity and capability of the Extractables & Leachables teams now driving Element Manchester’s medical devices testing services.
As Section Head – Technical, Jack now has responsibility for study oversight, data specialists and development scientists working together to deliver high quality Extractables & Leachables studies to support client submissions.
Element has one of the largest and most experienced extractables and leachables (E&L) practices in the world.
We deliver tailored E&L studies of pharmaceutical, biologic, medical device, reduced risk, combination products and more, in accordance with regulatory expectations.
